Podcasts
Clinical Insights on Dyskinesia and Tremor in Parkinson’s Disease
August 25th 2025Panelists discuss how distinguishing between dyskinesia (choreoform, dance-like movements) and tremor in Parkinson's disease is crucial for treatment decisions, as modern therapeutic options including extended-release amantadine, continuous subcutaneous delivery systems, and advanced formulations can now effectively manage both motor fluctuations and troublesome dyskinesias simultaneously.
B Cells as a Treatment Target in Myasthenia Gravis
August 4th 2025Ali Habib, MD, and Arjun Seth, MD, discuss how B-cell–targeted therapies represent a promising upstream treatment approach for myasthenia gravis that could provide more sustained efficacy compared with current downstream treatments like complement inhibitors and FcRn antagonists, with CD19-targeting agents like inebilizumab showing particular promise in clinical trials for both acetylcholine receptor and MuSK antibody subtypes.
VIDEO: Narcolepsy: From Diagnosis to Treatment—Insights From the Front Lines
July 16th 2025Panelists discuss the clinical presentation, diagnostic approaches, and treatment considerations for narcolepsy, offering practical insights to guide health care professionals new to its diagnosis and management.
PODCAST: Narcolepsy: From Diagnosis to Treatment—Insights From the Front Lines
July 15th 2025Panelists discuss the clinical presentation, diagnostic approaches, and treatment considerations for narcolepsy, offering practical insights to guide health care professionals new to its diagnosis and management.
Dyskinesia and Patient Communication in Parkinson Disease
April 28th 2025Panelists discuss how early recognition of dyskinesia symptoms, ongoing patient-clinician communication, and individualized treatment strategies are key to effectively managing Parkinson disease and improving patients’ quality of life.
Neurology Unwrapped: 2024’s Most Intriguing Conversations
December 27th 2024Mind Moments®, a podcast from NeurologyLive®, brings you a review of 2024, with insights from Daniel Ontaneda, MD, PhD; Ian Kremer; Andy Berkowski, MD, PhD; Sameea Husain-Wilson, DO; Jonathan Parker, MD, PhD; and Lawrence Robinson, MD. [LISTEN TIME: 25 minutes]
